Catalyst
Slingshot members are tracking this event:
Cempra (CEMP) Phase 3 SOLITAIRE-U Data Evaluating Solithromycin Compared to Standard of Care in Treatment of Uncomplicated Genitourinary Gonorrhea (GC) With or Without Concomitant Chlamydia
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CEMP |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 28, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 3, Solitaire-u, Solithromycin, Uncomplicated Genitourinary Gonorrhea, Concomitant Chlamydia
